Clinical trial
Effect of Theophylline in Pseudohypoparathyroidism
NCT03718403 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Theophylline in Pseudohypoparathyroidism
- Lead sponsor
- Massachusetts General Hospital
- Phase
- Phase 4
- Overall status
- Recruiting
- Start date
- November 11, 2019
- Completion date
- April 10, 2032
- Enrollment
- 100 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
php ia, php ib, php1c